4//SEC Filing
Bookman Michael 4
Accession 0001790340-24-000032
CIK 0001790340other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:14 PM ET
Size
5.6 KB
Accession
0001790340-24-000032
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
Transactions
- Award
Class A Common Stock
2024-03-15$1.62/sh+1,448$2,346→ 3,850 total
Footnotes (3)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the "ESPP"), for the ESPP purchase period of September 15, 2023 through March 15, 2024. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934.
- [F2]The relevant Offering Period (as defined in the ESPP) ended, and the shares were acquired, on the Purchase Date (as defined in the ESPP) of March 15, 2024.
- [F3]In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Purchase Date of March 15, 2024.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001840339
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 7:14 PM ET
- Size
- 5.6 KB